Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery
Source abstract
Abstract
A hyaluronic acid-containing ethosomes (HA-ES) as the transdermal drug delivery system was prepared in this work, and rhodamine B (RB) was used as a model drug to be encapsulated. The obtained HA-ES-RB was then characterized by the surface morphology, entrapment efficiency, drug loading and the stability. Results showed that the prepared HA-ES-RB was spherical and showed good dispersion as well as the stability, with a particle size of below 100 nm. The skin permeation experiments were carried out in vitro with the Franz diffusion cells and the rat dorsal skins were used. It was found that the penetration effect of HA-ES-RB was much better than that of ES-RB. The fluorescence microscopy image showed that HA-ES-RB penetrated into the deepest dermis. The excellent transdermic drug delivery effect of HA-ES-RB maybe attributed from its smaller size, hydration of hyaluronic acid as well as greater potential targeting to skin and skin appendages of liposomal carriers. Moreover, the HA-ES delivery system showed non-cytotoxicity to normal cells, indicating a good biocompatibility. This work provded a hyaluronic acid-containing ethosomes which can offer a quick, high efficient, safe and self-administered transdermal drug delivery system.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Dermatology and Skin Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Thermoresponsive polymeric gel as an on-demand transdermal drug delivery system for pain management10.1016/j.msec.2016.01.021 ↗
2. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: in vitro characterization and in vivo pharmacokinetic assessment10.1016/j.ijpharm.2016.03.030 ↗
3. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery10.1016/j.jconrel.2014.04.045 ↗
4. Improvement of transdermal delivery of exendin-4 using novel tip-loaded microneedle arrays fabricated from hyaluronic acid10.1021/acs.molpharmaceut.5b00765 ↗
5. Rapidly separating microneedles for transdermal drug delivery10.1016/j.actbio.2016.06.005 ↗
6. Liposomes and niosomes as potential carriers for dermal delivery of minoxidil10.1080/10611860600991993 ↗
7. Optimized permeation enhancer for topical delivery of 5-fluorouracil-loaded elastic liposome using Design Expert: part II10.3109/10717544.2015.1124473 ↗
8. Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol10.1016/j.ijpharm.2005.12.004 ↗
9. Enhanced delivery of drugs into and across the skin by ethosomal carriers10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M ↗
10. A novel approach for the use of hyaluronic acid-based hydrogel nanoparticles as effective carriers for transdermal delivery systems10.1016/j.colsurfa.2012.03.023 ↗
11. Physicochemical properties of pH-sensitive hydrogels based on hydroxyethyl cellulose–hyaluronic acid and for applications as transdermal delivery systems for skin lesions10.1016/j.ejpb.2015.02.025 ↗
12. Fennel-like nanoaggregates based on polysaccharide derivatives and their application in drug delivery10.1016/j.colsurfb.2013.09.027 ↗
13. In situ crosslinkable hydrogel formed from a polysaccharide-based hydrogelator10.1021/bm801500w ↗
14. Transdermal delivery of 10,11-methylenedioxycamptothecin by hyaluronic acid based nanoemulsion for inhibition of keloid fibroblast10.1016/j.carbpol.2014.05.026 ↗
15. Enhancing the transdermal penetration of nanoconstructs: could hyaluronic acid be the key?10.2217/nnm.14.47 ↗
16. A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery10.1016/j.biomaterials.2014.01.070 ↗
17. Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine10.1016/j.carbpol.2016.06.101 ↗
18. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles10.1080/10717544.2016.1204569 ↗
19. 5-Aminolevulinic acid loaded ethosomal vesicles with high entrapment efficiency for in vitro topical transdermal delivery and photodynamic therapy of hypertrophic scars10.1039/C6NR06872C ↗
20. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery10.1016/j.ejps.2017.06.025 ↗
21. Supramolecular organization and release properties of phospholipid-hyaluronan microparticles encapsulating dexamethasone10.1016/j.ejpb.2008.04.013 ↗
22. Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective10.1208/s12248-017-0142-0 ↗
23. Properties and in vitro drug release of hyaluronic acid-hydroxyethyl cellulose hydrogels for transdermal delivery of isoliquiritigenin10.1016/j.carbpol.2016.04.021 ↗
24. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy10.1039/C4CC08746A ↗
25. Transferrin-functionalized chitosan-graft-poly(Llysine) dendrons as a high-efficiency gene delivery carrier for nasopharyngeal carcinoma therapy10.1039/C8TB00489G ↗